Replies to post #184 on China Dom. Bio-tech Hldgs Inc. (fka CDBH)

[db7]

most china pharma/bio's i've seen come to market in the last year or so all seem to be profitable and trading over $2

we'll see what we get here

[DesertRat1]

Potse, thank you. I pretty much agree. Based on the name change I would expect something to happen relatively quickly.

[Potse]

CCKH...biotech/pharma reverse merger......

Several years ago I discovered that one way you can get some advance notice of a China reverse merger is by attaching the ".ob" to a shell's symbol and then searching Chinese websites for any hits. I have been doing the "CCKH.ob" search on a regular basis since the Nevada name change occurred, and tonight was the first time something noteworthy appeared.

I believe that CCKH is reverse merging with a China biotech/pharma. I have not been able to determine what the exact name of the company is, but based on the description it appears that the company is involved in technologies/products based on proteins derived from houseflies/insects (nutritional, drugs, skin care, burns, etc.).

I also wasn't able to determine whether the company is fully-operational/profitable or in the development stage. A couple of things that I did find and think are noteworthy......

1) In early 2009 a large investment fund/firm in China apparently acquired a nearly $12M stake in the company.

2) It appears that in January 2010 the company had a ground-breaking ceremony at an industrial park. This is a $31-48M, 300-acre investment, and following completion of the facilities either the company as a whole or just the new facilities will be capable of producing $220M in annual revenue.

CCKH.ob search of Chinese websites produced this interesting hit. On a Chinese Chamber of Commerce website, the following appears (translated)......

China Fly biomedical holding company is specialized in housefly insect active protein in the field of applied biomedical R & D, production and sales of high-tech biological pharmaceutical enterprises, the company of "science and technology to create a healthy, professional win the trust" business purposes, adhere to standards, the state of the high standards of philosophy as a guide, the product-oriented scientific research, patents, technology, innovation, relying on high-technology industries development. Company in the U.S. Nasdaq (NASDQ) successfully listed, listed code: CCKH.OB): Headquartered in Shenzhen, the company invested in 330 million yuan in Fuzhou, Jiangxi Fuzhou Sheng Yongsheng materials Pharmaceutical Co., Ltd. was established to build national CD the activity of a protein biomedical industry park.

http://webcache.googleusercontent.com/search?q=cache:cHqvkTN25D4J:szfzsh.com/file.php%3Fts_id%3D227%26weblan%3Dg+%22cckh.ob%22&cd=1&hl=en&ct=clnk&gl=us&lr=lang_zh-CN

Ground-breaking ceremony, and company description.....

Yesterday morning, ask the North Industrial Park, fireworks went off everywhere, from the U.S. NASDAQ listed company in China holding company, housefly biological industry invest property in Fuzhou Sheng Yongsheng Pharmaceutical Co., Ltd. started in the ground-breaking ceremony was held here. Municipal Committee, vice mayor Huang Mu Hong, Vice Mayor Johnson attended the groundbreaking ceremony Liu Ju.

Fuzhou Sheng Yongsheng property investment 210 million yuan Pharmaceutical Co., Ltd., covers an area of 300 acres, mainly depend on the parent company's technology as a backing. Its parent company owns the world's most advanced protein housefly biotransformation, biological pharmaceutical technology, can produce clinical nutrition protein, non-medical nutrition protein, skin care products, drugs, burns four major categories of 15 varieties of products, all raw materials are from insects - Musca domestica protein. After completion, the annual output up to 1.5 billion, and paid taxes 80 million yuan.

http://translate.google.com/translate?hl=en&sl=zh-CN&u=http://www.jxfz.gov.cn/xxgk/zdgc/yqjs/201001/t20100116_812753.htm&ei=dr2-S6m-NIzlnQeC1rW3Cg&sa=X&oi=translate&ct=result&resnum=2&ved=0CBAQ7gEwAQ&prev=/search%3Fq%3D%2522%25E4%25B8%25AD%25E5%259B%25BD%25E5%25AE%25B6%25E8%259D%2587%25E7%2594%259F%25E7%2589%25A9%2522%26hl%3Den%26lr%3D

[Potse]

IDCX/CCKH comparison....worth noting.....

"By the way, I see ACTN has traded a fair amount of shares around 18 cents today. That gives the ACTN shell shares a valuation of $3.3M. For comparison purposes, that is the equivalent of the CCKH shell (current market cap: $700k) trading at over $1.40/shr."

Belmont Partners sold ownership control of the IDCX shell last week, and it will probably be filled with a China-based company. IDCX is currently trading at a valuation more than 4x that of CCKH, and has a share structure significantly larger......

IDCX (.05) 68.2M outstanding, $3.4M market cap
CCKH (.35) 2.3M outstanding, $800k market cap